[22] [23] By activating GLP-1 receptors, these medications enhance insulin secretion when blood glucose levels are elevated, suppress glucagon release, slow gastric emptying, and promote satiety
In patients at increased risk for the development of renal impairment (e.g., the elderly), renal function should be assessed more frequently
The compounded formulation is prepared by licensed U.S.-based pharmacies that follow federal and state compounding guidelines
These preclinical findings support the further development and advancement of these small molecules as potential therapies for type 2 diabetes and obesity
Theyre created by pharmacies using the same active ingredient (semaglutide) as brand-name Ozempic and Wegovy, but they dont undergo the same rigorous testing and quality control processes that FDA-approved medications do
Prescription GLP-1 medications are synthetic versions of this hormone that are designed to mimic and enhance your body's own system by staying active longer